From vision
to reality

An investigator grant from the Australian National Health and Medical Research Council (NHMRC) for micromedical device development.

A clinical study funded by the Skin Cancer College of Australasia using microbiopsy to discover biomarkers for basal cell carcinoma (BCC).

How a novel micro-technology enabled a groundbreaking topical treatment for aging skin with minimal systemic risks.

An industry-sponsored clinical trial validating the use of microbiopsy for real-time PCR biomarker profiling of facial skin.

A collaboration with a leading cosmetics company on a groundbreaking, minimally invasive tool for skin profiling.

Identifying drugs that could be used in new ways to treat skin conditions without the high cost of de novo development.

A dose-escalation study to characterize the safety, pharmacokinetics and fluorescence imaging capability of BLZ-100 (tozuleristide) in adults with suspected glioma.

A Phase 1 clinical trial in patients with skin cancer evaluating the safety and tolerability of a novel imaging agent used to highlight cancer cells in real-time.

Collaborations with leading companies to develop innovative products and technologies for the future of skincare.